Use of 1, 3-beta-d-glucan concentration in peritoneal fluid for the diagnosis of intra-abdominal candidiasis in critically ill patients. (20th March 2023)
- Record Type:
- Journal Article
- Title:
- Use of 1, 3-beta-d-glucan concentration in peritoneal fluid for the diagnosis of intra-abdominal candidiasis in critically ill patients. (20th March 2023)
- Main Title:
- Use of 1, 3-beta-d-glucan concentration in peritoneal fluid for the diagnosis of intra-abdominal candidiasis in critically ill patients
- Authors:
- Nourry, Émilie
Wallet, Florent
Darien, Marie
Menotti, Jean
Dupont, Damien
Allaouchiche, Bernard
Argaud, Laurent
Richard, Jean-Christophe
Guichon, Céline
Rimmelé, Thomas
Bohe, Julien
Thiollère, Fabrice
Vassal, Olivia
Lepape, Alain
Wallon, Martine
Persat, Florence
Friggeri, Arnaud - Abstract:
- Abstract: Intra-abdominal candidiasis (IAC) is frequent and associated with high mortality in intensive care unit (ICU) patients. Antifungal treatments may be overused due to a lack of diagnostic tools to rule out IAC. Serum 1, 3-beta-d -glucan (BDG) concentrations are used to diagnose Candida infections, its concentration in peritoneal fluid (PF) may help to confirm or invalidate the diagnosis of IAC. We performed a non-interventional, prospective, multicenter study at the Hospices Civils de Lyon, France, in seven ICUs located in three different hospitals from December 2017 to June 2018. IAC was defined as the isolation of Candida in a sample collected from the intra-abdominal cavity under sterile conditions in patients displaying clinical evidence of intra-abdominal infection (IAI). Among the 113 included patients, 135 PF samples corresponding to 135 IAI episodes were collected and BDG concentrations were assessed. IAC accounted for 28 (20.7%) of the IAIs. Antifungals were administered empirically to 70 (61.9%) patients; among them, 23 (32.9%) had an IAC. The median [interquartile range] BDG value was significantly higher in IAC (8100 [3000; 15 000] pg/ml) than in non-IAC samples (1961 [332; 10 650] pg/ml). BDG concentrations were higher in PF with Fecaloid aspect and in case of positive bacterial culture. For a BDG threshold of 125 pg/ml, the negative predictive value to assess IAC was 100%. In conclusion, low BDG-PF concentrations could be used to rule out IAC.Abstract: Intra-abdominal candidiasis (IAC) is frequent and associated with high mortality in intensive care unit (ICU) patients. Antifungal treatments may be overused due to a lack of diagnostic tools to rule out IAC. Serum 1, 3-beta-d -glucan (BDG) concentrations are used to diagnose Candida infections, its concentration in peritoneal fluid (PF) may help to confirm or invalidate the diagnosis of IAC. We performed a non-interventional, prospective, multicenter study at the Hospices Civils de Lyon, France, in seven ICUs located in three different hospitals from December 2017 to June 2018. IAC was defined as the isolation of Candida in a sample collected from the intra-abdominal cavity under sterile conditions in patients displaying clinical evidence of intra-abdominal infection (IAI). Among the 113 included patients, 135 PF samples corresponding to 135 IAI episodes were collected and BDG concentrations were assessed. IAC accounted for 28 (20.7%) of the IAIs. Antifungals were administered empirically to 70 (61.9%) patients; among them, 23 (32.9%) had an IAC. The median [interquartile range] BDG value was significantly higher in IAC (8100 [3000; 15 000] pg/ml) than in non-IAC samples (1961 [332; 10 650] pg/ml). BDG concentrations were higher in PF with Fecaloid aspect and in case of positive bacterial culture. For a BDG threshold of 125 pg/ml, the negative predictive value to assess IAC was 100%. In conclusion, low BDG-PF concentrations could be used to rule out IAC. https://clinicaltrials.gov/ct2/show/NCT03469401 Lay Summary: Intra-abdominal candidiasis (IAC) is associated with a high mortality in intensive care unit (ICU) patients. 1, 3-beta-d -glucan (BDG), a component of Candida cell wall, was prospectively measured in peritoneal fluid from ICU patients Low peritoneal BDG concentrations may be used to rule out IAC … (more)
- Is Part Of:
- Medical mycology. Volume 61:Number 3(2023)
- Journal:
- Medical mycology
- Issue:
- Volume 61:Number 3(2023)
- Issue Display:
- Volume 61, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 61
- Issue:
- 3
- Issue Sort Value:
- 2023-0061-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-03-20
- Subjects:
- intra-abdominal infection -- intensive care -- Candida -- 1, 3-beta-d-glucan -- diagnostic
Medical mycology -- Periodicals
Veterinary mycology -- Periodicals
Mycology -- Periodicals
Mycoses -- Periodicals
Pathogenic fungi -- Periodicals
616.969005 - Journal URLs:
- http://mmy.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/mmy/myad029 ↗
- Languages:
- English
- ISSNs:
- 1369-3786
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5530.168000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26799.xml